United States · 
Who invested in RxLightning?
RxLightning's investors include Hearst Ventures, Novartis and LRVHealth.
United States · Series A startup
Who invested in RxLightning
Funding summaryUpdated 26 Oct 2026
$18Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $18MJun 2023
- Investors
- 3
The rounds
- Jun 2023Series A$18M
Source recordedSEC filing: $17M sold, first sale May 2023
Founders and team
From RxLightning's own website and the SEC filings it signed: 2 founders, 6 on the team.
Brad AllenCo-Founder and Chief Technology OfficerNamed on its 2023 Form D
- Brad FluegelBoard Member
- Carrie WilliamsBoard Member
- Jared KlingeisenExecutive Officeri
- Josh FlumBoard Member
- Kathleen BresetteExecutive Officeri
- Mark BakkenBoard Member
On the board, as filediBradley Fluegel
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list RxLightning as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about RxLightning
How much has RxLightning raised?
RxLightning has raised $18M across 1 round since 2023.
When did RxLightning last raise?
RxLightning's most recent round was a Series A of $18M in Jun 2023.
What was RxLightning's biggest round?
Its most recent round, $18M in Jun 2023, is also its largest on record.
Who backed RxLightning first?
RxLightning's first round on record, in Jun 2023, was backed by Hearst Ventures, Novartis and LRVHealth.
What stage is RxLightning at?
RxLightning's latest named round is a Series A, in Jun 2023.
Where is RxLightning based?
RxLightning is based in the United States.
Companies like RxLightning
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.